Researchers evaluate the effectiveness of a novel extracorporeal total artificial lung system to enable bilateral pneumonectomy in patients with severe ARDS.

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.

The ATS/ERS 2025 statement on interstitial pneumonia classification updates the 2013 statement, with insights on secondary ...

RESEARCHERS have developed a cutting-edge human lung-on-chip system, called iLoC, that could transform how clinicians and scientists study respiratory infections, including tuberculosis (TB). Unlike ...

When exposed to various stimuli, monocytes/macrophages are recruited to and retained within the local tissue microenvironment, where they can activate and display either proinflammatory or ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act as guardians, keeping the lungs healthy, supporting breathing, and ...

Alveolar macrophages are immune cells that live in the tiny air sacs of the lungs. Under normal conditions, these cells act as guardians, keeping the lungs healthy, supporting breathing, and ...

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare disease characterized by progressive surfactant accumulation and hypoxemia caused by autoantibodies against granulocyte–macrophage ...

CARBON accumulation in alveolar macrophages is significantly elevated in patients with chronic obstructive pulmonary disease (COPD) compared to smokers and is closely associated with reduced lung ...

Lung macrophages, a type of white blood cell vital for immune defense, play a crucial role in conditions such as idiopathic pulmonary fibrosis (IPF). There are two main varieties of these cells in the ...